Critics say thelegislation goes too far in limiting drugmakers’ discretion to setprices and doesn’t do enough to help consumers. (Photo:Shutterstock)
A bipartisan Senate bill would yield $100 billion in savings onprescription-drug spending over a decade, twoof its sponsors said, in part by penalizing pharmaceuticalcompanies for raising prices faster than the rate of inflation.
The legislation, which has the backing of the White House,contains several proposals designed to reduce government outlays inMedicare and Medicaid. It also seeks to limit what patients whohave Medicare drug plans would have to spend out of their ownpockets on prescriptions.
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
